IMCD completed the acquisition of Signet Excipients Private.

IMCD, a global distributor of speciality chemicals and food and pharma ingredients, completed the acquisition of Signet Excipients Private, an Indian speciality chemicals distributor. Financial terms were not disclosed. “As India is the largest supplier of generic medicines globally, it is our ambition for our pharmaceutical business to have a strong presence there. Hence, I am pleased that Signet and IMCD will now join their activities in India, Bangladesh, the Middle East and Africa,” Piet van der Slikke, IMCD CEO. On February 01, 2024, IMCD completed the acquisition of remaining 30% of Signet Excipients.